A male patient underwent an aquablation procedure for symptomatic benign prostatic hyperplasia (bph).Procept biorobotics corporation (procept) became aware that after the first treatment pass, the patient coded and the procedure was aborted.The patient was resuscitated after 13 minutes and his heart was stabilized.Additionally, it was reported that the patient's prostate was embolized.It was reported that the patient was being monitored in the intensive care unit.Multiple follow-up attempts for additional information from the hospital have not been successful; however, as of 19-mar-2024, it was reported that the patient is improving.No malfunction of the aquabeam robotic system was reported.
|
Additional information was received on 18-apr-2024 indicating that the patient had a pre-existing clot prior to aquablation therapy that was missed during cardiac clearance.The clot made its way to the patient's heart during aquablation therapy, causing the patient to code.The aquabeam robotic system is a reusable device; therefore it is currently in the possession of the user facility.The investigation of this event consisted of a review of the treatment log files, device history record (dhr), and instructions for use (ifu).The aquabeam robotic system's treatment logs file was reviewed, which confirmed no malfunctions during the aquablation procedure.The review of the treatment logs indicated that the system functioned as designed.A review of the device history record (dhr) ab2000-b/serial number (b)(6) was conducted, which confirmed that there were no non-conformances, failures, discrepancies, or missed steps during the manufacturing process that could be related to the reported event.The review indicated that the system met all design and manufacturing specifications when released for distribution.The aquabeam robotic system's instructions for use (ifu), ifu0101-00, rev.E, was reviewed and states the following: 3.Contraindications: do not use the aquabeam robotic system in patients who do not meet the indication for the system's intended use.The aquabeam robotic system is a reusable device; therefore, it is currently in possession of the user facility.It was reported that patient had a pre-existing clot prior to aquablation therapy that was missed during cardiac clearance.The clot made its way to the patient's heart during aquablation therapy, causing the patient to code.Based on the event details, plus a review of the treatment log files, dhr, and ifu, the event is considered not to be device-related.Submission of this report does not constitute an admission that the manufacturer's product caused or contributed to the event.
|
H11.Additional manufacturer narrative: additional information received on 05-apr-2024 from the sales representative indicating the patient has made a "great" recovery, is fully conscious, and functioning.The treating surgeon took the patient back to the operating room to look at his prostate and after one completed aquablation pass, the patient's channel is "wide open".It was reported that the patient has been discharged from the hospital.
|